A citation-based method for searching scientific literature

Alexander D McLellan, Seyed M Ali Hosseini Rad. Immunol Cell Biol 2019
Times Cited: 96



Daniel W Lee, James N Kochenderfer, Maryalice Stetler-Stevenson, Yongzhi K Cui, Cindy Delbrook, Steven A Feldman, Terry J Fry, Rimas Orentas, Marianna Sabatino, Nirali N Shah, Seth M Steinberg, Dave Stroncek, Nick Tschernia, Constance Yuan, Hua Zhang, Ling Zhang, Steven A Rosenberg, Alan S Wayne, Crystal L Mackall. Lancet 2015
Times Cited: 1890




List of shared articles



Times cited

Bioinstructive implantable scaffolds for rapid in vivo manufacture and release of CAR-T cells.
Pritha Agarwalla, Edikan A Ogunnaike, Sarah Ahn, Kristen A Froehlich, Anton Jansson, Frances S Ligler, Gianpietro Dotti, Yevgeny Brudno. Nat Biotechnol 2022
7

Chimeric antigen receptor T-cell therapies: Optimising the dose.
Nathaniel Dasyam, Philip George, Robert Weinkove. Br J Clin Pharmacol 2020
8

Challenges and Clinical Strategies of CAR T-Cell Therapy for Acute Lymphoblastic Leukemia: Overview and Developments.
Xinjie Xu, Shengkang Huang, Xinyi Xiao, Qihang Sun, Xiaoqian Liang, Sifei Chen, Zijing Zhao, Zhaochang Huo, Sanfang Tu, Yuhua Li. Front Immunol 2021
9

Case Report: Humanized Selective CD19CAR-T Treatment Induces MRD-Negative Remission in a Pediatric B-ALL Patient With Primary Resistance to Murine-Based CD19CAR-T Therapy.
Kai Wang, Yu Zhao, Xuan Wang, Bin Wang, Maoquan Qin, Guanghua Zhu, Huantong Wu, Zhongfeng Liu, Xueling Zheng, Huyong Zheng,[...]. Front Immunol 2020
1

The Application of CAR-T Cells in Haematological Malignancies.
Katarzyna Skorka, Katarzyna Ostapinska, Aneta Malesa, Krzysztof Giannopoulos. Arch Immunol Ther Exp (Warsz) 2020
11

Determinants of response and resistance to CAR T cell therapy.
Stefanie Lesch, Mohamed-Reda Benmebarek, Bruno L Cadilha, Stefan Stoiber, Marion Subklewe, Stefan Endres, Sebastian Kobold. Semin Cancer Biol 2020
43

Antigen-Specific TCR-T Cells for Acute Myeloid Leukemia: State of the Art and Challenges.
Synat Kang, Yisheng Li, Jingqiao Qiao, Xiangyu Meng, Ziqian He, Xuefeng Gao, Li Yu. Front Oncol 2022
3

Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia.
Runxia Gu, Fang Liu, Dehui Zou, Yingxi Xu, Yang Lu, Bingcheng Liu, Wei Liu, Xiaojuan Chen, Kaiqi Liu, Ye Guo,[...]. J Hematol Oncol 2020
19

Exhaustion of CAR T cells: potential causes and solutions.
Taku Kouro, Hidetomo Himuro, Tetsuro Sasada. J Transl Med 2022
1

CAR-T therapy: Prospects in targeting cancer stem cells.
Xiaoyue Cui, Rui Liu, Lian Duan, Dan Cao, Qiaoling Zhang, Aijie Zhang. J Cell Mol Med 2021
6

Improving CAR T-Cell Persistence.
Violena Pietrobon, Lauren Anne Todd, Anghsumala Goswami, Ofir Stefanson, Zhifen Yang, Francesco Marincola. Int J Mol Sci 2021
6

Genetic Modification of Cytokine Signaling to Enhance Efficacy of CAR T Cell Therapy in Solid Tumors.
Navid Ghahri-Saremi, Behnia Akbari, Tahereh Soltantoyeh, Jamshid Hadjati, Saba Ghassemi, Hamid Reza Mirzaei. Front Immunol 2021
2